The Rhodadyns, a New Class of Small Molecule Inhibitors of Dynamin GTPase Activity
Overview
Authors
Affiliations
Six focused rhodanine-based libraries, 60 compounds in total, were synthesized and evaluated as potential dynamin I GTPase inhibitors. Twenty-six were more potent than the lead compound with 13 returning IC50 values ≤10 μM, making the Rhodadyn series among the most active dynamin inhibitors reported. Two analogues were highly effective at blocking receptor-mediated endocytosis: C10 and D10 with IC50(RME) = 7.0 ± 2.2 and 5.9 ± 1.0 μM, respectively. These compounds are equipotent with the best reported in-cell dynamin inhibitors.
The Chemical Inhibitors of Endocytosis: From Mechanisms to Potential Clinical Applications.
Szewczyk-Roszczenko O, Roszczenko P, Shmakova A, Finiuk N, Holota S, Lesyk R Cells. 2023; 12(18).
PMID: 37759535 PMC: 10527932. DOI: 10.3390/cells12182312.
Odell L, Jones N, Chau N, Robertson M, Ambrus J, Deane F RSC Med Chem. 2023; 14(8):1492-1511.
PMID: 37593570 PMC: 10429932. DOI: 10.1039/d2md00371f.
Hessien M, Donia T, Tabll A, Adly E, Abdelhafez T, Attia A Viruses. 2023; 15(5).
PMID: 37243127 PMC: 10222743. DOI: 10.3390/v15051040.
Prodrugs of the Archetypal Dynamin Inhibitor Bis-T-22.
Odell L, Robertson M, Young K, McGeachie A, Quan A, Robinson P ChemMedChem. 2022; 17(24):e202200400.
PMID: 36351775 PMC: 10947042. DOI: 10.1002/cmdc.202200400.
Insight into the role of clathrin-mediated endocytosis inhibitors in SARS-CoV-2 infection.
Sami Alkafaas S, Abdallah A, Ghosh S, Loutfy S, Samy ElKafas S, Abdel Fattah N Rev Med Virol. 2022; 33(1):e2403.
PMID: 36345157 PMC: 9877911. DOI: 10.1002/rmv.2403.